tbuckley/cabot-search huggingface dataset:
FRI0434 PREDICTIVE FACTORS OF SERIOUS INFECTIONS IN PATIENTS WITH CHRONIC INFLAMMATORY ARTHRITIS ON TREATMENT WITH TNF INHIBITORS: REAL LIFE DATA
Authors: A. Ruiz Ochoa, J. Escudero Argaluza, B. Alvarez Rodríguez, M. Vasques Rocha, C. Stoye, O. Pompei Fernández, S. Gil, J. R. De Dios, J. Calvo-Alen
Journal: Annals of the Rheumatic Diseases (2020)

Background: Serious infections are one of the most feared adverse events in patients treated with biologics. To this regard data coming from randomized and long-term extension studies may not totally applied to the usual clinical practice due to the different profile of the treated patients. To study the associated factors for serious infections in patients with inflammatory arthritis treated with TNF inhibitors Objectives: To study the associated factors for serious infections in patients with inflammatory arthritis treated with TNF inhibitors Methods: All the medical records of the patients with inflammatory arthritis being treated with TNF inhibitors at the beginning of 2016 were retrospectively reviewed. All serious infections suffered for these patients until the end of 2018 were recorded. Serious infections were defined as those which required to admitted at the hospital for intravenous treatment. Potential variables associated with the development of these infections including: demographic and clinical characteristics, concomitant treatments or comorbidity (by Charlson index) were studied. Standard statistical tests for descriptive and univariate analyses were used and a multivariable logistic regression model was built to check independent associations. Results: Overall 334 patients (50.3% women) with a mean age of 56.67 (±12.853) were studied: 140 (41.92%) Rheumatoid arthritis (RA), 55 (16.46%) psoriatic arthritis (PsA) and 138 (41.62%) spondyloarthritis (Sp). Forty-five serious infections were observed in 30 patients, being respiratory (40%) and urinary (8.8%) the most frequent localizations. Only one patient died. By univariate analysis, disease duration, age, concomitan use of glucocorticoids (GC) (but not of synthetic DMARDs), Charlson index and specifically Diabetes Mellitus were associated with infection (p&lt; 0.05). The type of arthritis was not associated and the results in the subset of RA patients were overall similar. In the multivariate analysis the use of GC [OR: 5.31 (1.98.14.26)] and the Charlson index [OR:2.48 (1.70;3.60)] were found to be independently associated to infection. Conclusion: In patients with inflammatory arthritis and treated with TNF inhibitors around a 10% developed any serious infection along three years of follow up. Use of GC and comorbidity emerged as the main risk factors for this complication. Disclosure of Interests: None declared
Food Deserts Are Associated with Acute Care Utilization Among Preschool Children with Sickle Cell Disease
Authors: Hamda Khan, Nariman Ammar, Jerlym S. Porter, Juan Ding, Jeremie H. Estepp, Jason R. Hodges, Arash Shaban-Nejad, Winfred Wang, James G Gurney, Guolian Kang, Robert Davis, Jane S. Hankins
Journal: Blood (2020)
Preclinical Development of AT1412, a Patient Derived CD9 Antibody That Does Not Induce Thrombosis for Treatment of B ALL
Authors: Remko Schotte, Julien Villaudy, Greta De Jong, Viviana Neviani, Wouter Pos, Sophie E Levie, Daniel M Go, Etsuko Yasuda, Esmay Frankin, Madalina Cercel, Susan E van Hal-van Veen, Dorien van de Berg, Anikó Szabó, Christien Fatmawati, Martijn Kedde, Yvonne Claassen, Sjeng Horbach, Anita W Rijneveld, Piet Gros, Hergen Spits, Mette D Hazenberg, Hans van Eenennaam
Journal: Blood (2020)
Impact of Genetic Abnormalities and Measurable Residual Disease Levels on Outcome in Patients with MDS/AML Pre-Emptively Treated with Azacitidine: Correlative Results of the Prospective RELAZA2 Trial
Authors: Sabine Kayser, Jan Moritz Middeke, Michael Kramer, Katja Sockel, Sebastian Stasik, Regina Herbst, Lars R. Fransecky, Dominik Wolf, Schumacher Martin, Alwin Krämer, Richard Noppeney, Juergen Novotny, Gesine Bug, Katharina S. Götze, Karsten Spiekermann, Matthias Stelljes, Jan-Henrik Mikesch, Marion Subklewe, Antje Schubert, Anke Mütherig, Tilmann Bochtler, Marika Mende, Friedrich Stoelzel, Anne Kubasch, Malte Von Bonin, Mathias Haenel, Ulrich Duehrsen, Johannes Schetelig, Christoph Rollig, Claudia D Baldus, Gerhard Ehninger, Carsten Müller-Tidow, Hubert Serve, Martin Bornhäuser, Uwe Platzbecker, Christian Thiede
Journal: Blood (2020)
A Phase 1b Study of Eltrombopag and Azacitidine in Patients with High Risk Myelodysplastic Syndromes and Related Disorders
Authors: Alex Sternberg, Rebecca H. Boucher, Helen C Coulthard, Manoj Raghavan, Dominic J. Culligan, Aimee Jackson, Catherine Cargo, Mike Dennis, Marlen Metzner, Rachel Moore, David Bowen, Paresh Vyas
Journal: Blood (2020)
Efficacy and Safety of Front-Line Nilotinib Treatment and Discontinuation in Older Patients (≥65 years) with Chronic Myeloid Leukemia in Chronic Phase Who Have Achieved MR4.5: Results from ENESTfreedom
Authors: Jose Valentín García Gutiérrez, Jerald P. Radich, Andreas Hochhaus, Giuseppe Saglio, Tamas Masszi, Andrzej Hellmann, Jesper Stentoft, María Teresa Gomez Casares, Eibhlin Conneally, Philipp D le Coutre, Norbert Gattermann, Bruno Martino, Susanne Saussele, Francis J. Giles, Paola Aimone, Sai Li, Ksenia Titorenko, David M. Ross
Journal: Blood (2020)
Protective Effects of Daratumumab on Carfilzomib-Related Cardiac Dysfunction in Patients with Relapsed Multiple Myeloma: Results from an Observational Study
Authors: Evangelos Terpos, Kimon Stamatelopoulos, Nikolaos Makris, Ageliki Laina, Maria Gavriatopoulou, Georgios Georgiopoulos, Evangelos Eleutherakis-Papaiakovou, Despina Fotiou, Nikolaos Kanellias, Ioanna Dialoupi, Dimitris Delialis, Efstathios Manios, Magdalini Migkou, Maria Roussou, Aristea-Maria Papanota, Eleni-Dimitra Papanagnou, Maria Kotsopoulou, Ioannis P. Trougakos, Meletios A Dimopoulos, Efstathios Kastritis
Journal: Blood (2020)
Genomic Analysis of Diffuse Large B Cell Lymphoma in a Japanese Cohort Using Targeted DNA Sequencing
Authors: Tatsuzo Mishina, Nagisa Oshima-Hasegawa, Shokichi Tsukamoto, Masaki Fukuyo, Hajime Kageyama, Bahityar Rahmutulla, Yurie Nagai, Kensuke Kayamori, Yutaro Hino, Tomoya Muto, Shio Mitsukawa, Yusuke Takeda, Naoya Mimura, Chikako Ohwada, Masahiro Takeuchi, Hideki Tsujimura, Tohru Iseki, Chiaki Nakaseko, Jun-ichiro Ikeda, Makiko Itami, Koutaro Yokote, Osamu Ohara, Atsushi Kaneda, Emiko Sakaida
Journal: Blood (2020)
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study
Authors: Corey Cutler, Stephanie J. Lee, Sally Arai, Marcello Rotta, Behyar Zoghi, Aleksandr Lazaryan, Aravind Ramakrishnan, Zachariah DeFilipp, Amandeep Salhotra, Wanxing Chai-Ho, Rohtesh Mehta, Trent Wang, Mukta Arora, Iskra Pusic, Ayman Saad, Nirav N. Shah, Sunil Abhyankar, Carlos Bachier, John Galvin, Annie Im, Amelia Langston, Jane Liesveld, Mark Juckett, Aaron Logan, Levanto Schachter, Asif Alavi, Dianna Howard, Harlan W. Waksal, John Ryan, David Eiznhamer, Sanjay K. Aggarwal, Jonathan Ieyoub, Olivier Schueller, Laurie Green, Zhongming Yang, Heidi Krenz, Madan Jagasia, Bruce R. Blazar, Steven Pavletic
Journal: Blood (2021)
THU0041 Distinct effects of tnfalpha blockade from tnfalpha and ltalpha blockade in a primate model of subcutaneous abscess formation
Authors: XR Song, F Fox, MA Gallo, A Rosenberg, R Jordan, C Wagner
Journal: Annals of the Rheumatic Diseases (2001)

<h3>Background</h3> TNFα exerts both physiologic and pathologic effects in response to infection conferring the benefit of host defense against infection at the risk of eliciting severe pathology if the response is excessive or inappropriate. <h3>Objectives</h3> To examine whether the currently used anti-TNF therapy would affect the innate response to infections in an animal model of subcutaneous abscess formation. <h3>Methods</h3> Cynomolgus monkeys were randomly assigned to three treatment groups (saline, etanercept, and anti-TNFα Mab) by body weight and each group contained two male and two female monkeys. Abscess formation was induced with subcutaneous inoculation of<i> Staphylococcus</i><i>aureus</i>. <h3>Results</h3> Intravenous administration of anti-TNFα Mab on days -7, -3, 1, and 4 delayed the onset and reduced the incidence and the severity of <i>S.</i><i>aureus</i>-induced abscess formation as compared with the saline-treated group at both 10<sup>9</sup> and 10<sup>10</sup> CFU/ml of bacterial inocula given on day 1. Incontrast, no improvement in subcutaneous abscess formation as measured by swelling scores was observed in the receptor construct-treated animals as compared with the saline-treated animals when delivered with the same regimen at the same doses as anti-TNFα Mab. Rather, treatment with receptor construct resulted in a modest increase in the incidence and severity of abscess formation with inocula of 10<sup>9</sup> and 10<sup>10</sup> CFU/ml. <h3>Conclusion</h3> Our results provide the initial evidence that a specific anti-TNFα monoclonal antibody therapy administered at 3 mg/kg provides a beneficial effect against <i>S. aureus</i>-induced infection as shown in this non-human primate model of abscess formation.
Consolidation Treatment with VRD Followed By Maintenance Therapy Versus Maintenance Alone in Newly Diagnosed, Transplant-Eligible Patients with Multiple Myeloma (MM): A Randomized Phase 3 Trial of the European Myeloma Network (EMN02/HO95)
Authors: Pieter Sonneveld, Meral Beksac, Bronno Van Der Holt, Meletios A Dimopoulos, Angelo Michele Carella, Heinz Ludwig, Sonja Zweegman, Thilo Zander, Ruth Wester, Roman Hajek, Lucia Pantani, Luca Dozza, Francesca Gay, Anna Maria Cafro, Luca De Rosa, Francesca Fioritoni, Ulf-Henrik Mellqvist, Rossella Troia, Niels Frost Andersen, Ka Lung Wu, Christoph Driessen, Susana Carvalho, Alexandra J. Croockewit, Fredrik Schjesvold, Massimo Offidani, Michele Cavo, Mario Boccadoro
Journal: Blood (2020)
Eosinophils Protect Mice From Angiotensin-II Perfusion–Induced Abdominal Aortic Aneurysm
Authors: Cong-Lin Liu, Xin Liu, Yuanyuan Zhang, Jing Liu, Chongzhe Yang, Songyuan Luo, Tianxiao Liu, Yunzhe Wang, Jes S. Lindholt, Axel Diederichsen, Lars M. Rasmussen, Marie Dahl, Galina K. Sukhova, Guanyi Lu, Gilbert R. Upchurch, Peter Libby, Junli Guo, Jinying Zhang, Guo-Ping Shi
Journal: Circulation Research (2020)

Blood eosinophil count and ECP (eosinophil cationic protein) associate with human cardiovascular diseases. Yet, whether eosinophils play a role in cardiovascular disease remains untested. The current study detected eosinophil accumulation in human and murine abdominal aortic aneurysm (AAA) lesions, suggesting eosinophil participation in this aortic disease.
Treatment of infarcted heart tissue via the capture and local delivery of circulating exosomes through antibody-conjugated magnetic nanoparticles
Authors: Shiyu Liu, Xin Chen, Lili Bao, Tao Liu, Pingyun Yuan, Xiaoshan Yang, Xinyu Qiu, J. Justin Gooding, Yongkang Bai, Jiajia Xiao, Fengxing Pu, Yan Jin
Journal: Nature Biomedical Engineering (2020)
Prognostic Value of P53 and Myc Protein Expression in Follicular Lymphomas in the PRIMA Trial in the Lysa Group
Authors: Danielle Canioni, Laure Joseph, Bettina Fabiani, Catherine Chassagne-Clément, Peggy Dartigues-Cuillères, Frederic Charlotte, Pauline Brice, Pierre Feugier, Franck Morschhauser, Anne Sonet, Gilles Salles, Luc Xerri
Journal: Blood (2017)
Complicated Carotid Artery Plaques as a Cause of Cryptogenic Stroke
Authors: Anna Kopczak, Andreas Schindler, Anna Bayer-Karpinska, Mia L. Koch, Dominik Sepp, Julia Zeller, Christoph Strecker, Johann-Martin Hempel, Chun Yuan, Rainer Malik, Frank A. Wollenweber, Tobias Boeckh-Behrens, Clemens C. Cyran, Andreas Helck, Andreas Harloff, Ulf Ziemann, Sven Poli, Holger Poppert, Martin Dichgans, Tobias Saam
Journal: Journal of the American College of Cardiology (2020)

The underlying etiology of ischemic stroke remains unknown in up to 30% of patients.This study explored the causal role of complicated (American Heart Association-lesion type VI) nonstenosing carotid artery plaques (CAPs) in cryptogenic stroke (CS).CAPIAS (Carotid Plaque Imaging in Acute Stroke) is an observational multicenter study that prospectively recruited patients aged older than 49 years with acute ischemic stroke that was restricted to the territory of a single carotid artery on brain magnetic resonance imaging (MRI) and unilateral or bilateral CAP (≥2 mm, NASCET [North American Symptomatic Carotid Endarterectomy Trial] <70%). CAP characteristics were determined qualitatively and quantitatively by high-resolution, contrast-enhanced carotid MRI at 3T using dedicated surface coils. The pre-specified study hypotheses were that that the prevalence of complicated CAP would be higher ipsilateral to the infarct than contralateral to the infarct in CS and higher in CS compared with patients with cardioembolic or small vessel stroke (CES/SVS) as a combined reference group. Patients with large artery stroke (LAS) and NASCET 50% to 69% stenosis served as an additional comparison group.Among 234 recruited patients, 196 had either CS (n = 104), CES/SVS (n = 79), or LAS (n = 19) and complete carotid MRI data. The prevalence of complicated CAP in patients with CS was significantly higher ipsilateral (31%) to the infarct compared with contralateral to the infarct (12%; p = 0.0005). Moreover, the prevalence of ipsilateral complicated CAP was significantly higher in CS (31%) compared with CES/SVS (15%; p = 0.02) and lower in CS compared with LAS (68%; p = 0.003). Lipid-rich and/or necrotic cores in ipsilateral CAP were significantly larger in CS compared with CES/SVS (p < 0.05).These findings substantiate the role of complicated nonstenosing CAP as an under-recognized cause of stroke. (Carotid Plaque Imaging in Acute Stroke [CAPIAS]; NCT01284933).
Abstract 556: Deficiency of Probhitin-1 in Hepatocytes Alters Systemic Glucose Regulation
Authors: Katie Weihbrecht, Jo Mahoney, Ethan J Anderson
Journal: Circulation Research (2020)

Prohibitins 1 and 2 (PHB1 and PHB2) are lipid raft proteins that form a hetero-oligomeric complex known to localize to the cytoplasmic, nuclear, and mitochondrial membranes. These complexes play important roles in pro-survival and metabolic decisions including inflammation. PHB1 is important for mitochondria biogenesis and function and is excreted into the serum. Mice challenged with an intraperitoneal injection of lipopolysaccharide (LPS), a treatment that normally results in decreased cardiac function, show increased serum PHB. Injection of recombinant PHB1 (rPHB1) following LPS injection can rescue cardiac function. Work in our lab with cultured cardiomyocytes and multiple rodent models of severe sepsis supports the hypothesis that PHB1 is a liver-derived acute phase protein. To test this hypothesis, we utilized AAV- Cre recombinase infection driven by human thyroid hormone-binding globulin (TBG), a liver specific promotor (AAV8-TBG-iCre), on our PHB1 floxed mice (PHB1 fl/fl ). This liver specific knockdown of PHB1 allowed us to look at PHB1 levels in the serum of unstressed PHB1 fl/fl mice. We discovered a loss of PHB1 in the liver tissue of floxed mice and significantly lower serum levels of PHB was found in homozygotes compared to wild types. Additionally, mice with liver specific loss of PHB1 show metabolic changes including significant weight loss three weeks following injection and changes to body composition and a trend of decreases in brown fat and inguinal fat mass. In addition to these body changes, we found that liver specific loss resulted in sexual dimorphism in insulin sensitivity. Homozygous males showed a significant difference in their ability to clear glucose following a glucose challenge in a glucose tolerance test. However, following an insulin tolerance test, female homozygotes showed increased insulin sensitivity where males did not. Both males and females show a trend towards attenuated gluconeogenesis following a pyruvate tolerance test. Overall, we have begun to characterize novel findings to the metabolic state of mice lacking PHB1 only in the liver. Our aim is to further explore if these differences are due to the changes in liver PHB1 or due to changes in circulating serum PHB1.
Implication of Piga Genotype on Clinical Features of PNH
Authors: Carmelo Gurnari, Simona Pagliuca, Bhumika J. Patel, Hassan Awada, Cassandra M Kerr, Sunisa Kongkiatkamon, Laila Terkawi, Misam Zawit, Valeria Visconte, Adam Wahida, Jaroslaw P. Maciejewski
Journal: Blood (2020)
Drepadom - Home Care Services and Hospitalizations for Sickle Cell Disease Patients during the Covid-19 Pandemic
Authors: Gonzalo De Luna, Nicolas Lemonier, Alexis Aidan, Lea Bontemps, Manuel Hautefaye, Hadrien Diakonoff, Cecile Aubrun, Anne-Laure Pham Hung D'Alexandry D'Orengiani, Dora Bachir, Françoise Driss, Amna Jebali, Anoosha Habibi, Pablo Bartolucci
Journal: Blood (2020)
Genetic Determinants and Evolutionary History of Richter's Syndrome
Authors: Erin Michelle Parry, Romain Guieze, Ignaty Leshchiner, Daniel Rosebrock, Bria Persaud, Camilla K Lemvigh, Eugen Tausch, Matthew S. Davids, Johannes Bloehdorn, Christof Schneider, Liudmila Elagina, Aina Zurita Martinez, Amaro Taylor-Weiner, Nitin Jain, William G. Wierda, Laura Z. Rassenti, Thomas J. Kipps, Julien Broséus, Florence Cymbalista, Neil E. Kay, Kenneth J. Livak, Shuqiang Li, Teddy Huang, Noelia Purroy, Annabelle J Anandappa, Stacey M. Fernandes, Filippo Utro, Kahn Rhrissorrakrai, Chaya Levovitz, Brian P Danysh, Kara Slowik, Sameer A. Parikh, Jennifer R Brown, Laxmi Parida, Donna S. Neuberg, Stephan Stilgenbauer, Gad Getz, Catherine J. Wu
Journal: Blood (2020)
A Non-covalent Ligand Reveals Biased Agonism of the TRPA1 Ion Channel
Authors: Chang Liu, Rebecca Reese, Simon Vu, Lionel Rougé, Shannon D. Shields, Satoko Kakiuchi-Kiyota, Huifen Chen, Kevin Johnson, Yu Patrick Shi, Tania Chernov-Rogan, Demi Maria Zabala Greiner, Pawan Bir Kohli, David Hackos, Bobby Brillantes, Christine Tam, Tianbo Li, Jianyong Wang, Brian Safina, Steve Magnuson, Matthew Volgraf, Jian Payandeh, Jie Zheng, Alexis Rohou, Jun Chen
Journal: Neuron (2020)
BAFFR controls early memory B cell responses but is dispensable for germinal center function
Authors: Angelica W.Y. Lau, Vivian M. Turner, Katherine Bourne, Jana R. Hermes, Tyani D. Chan, Robert Brink
Journal: The Journal of Experimental Medicine (2020)

The TNF superfamily ligand BAFF maintains the survival of naive B cells by signaling through its surface receptor, BAFFR. Activated B cells maintain expression of BAFFR after they differentiate into germinal center (GC) or memory B cells (MBCs). However, the functions of BAFFR in these antigen-experienced B cell populations remain unclear. Here, we show that B cell–intrinsic BAFFR does not play a significant role in the survival or function of GC B cells or in the generation of the somatically mutated MBCs derived from them. Instead, BAFF/BAFFR signaling was required to generate the unmutated, GC-independent MBCs that differentiate directly from activated B cell blasts early in the response. Furthermore, amplification of BAFFR signaling in responding B cells did not affect GCs or the generation of GC-derived MBCs but greatly expanded the GC-independent MBC response. Although BAFF/BAFFR signaling specifically controlled the formation of the GC-independent MBC response, both types of MBCs required input from this pathway for optimal long-term survival.
High Level of Successful TKI Discontinuation in Chronic Myeloid Leukemia (CML) Patients: Preliminary Results of AST-Argentina Stop Trial
Authors: Carolina Pavlovsky, Ana Ines Varela, Isolda I. Fernandez, Maria Belen Sanchez, Maria Del Rosario Custidiano, Josefina Freitas, Veronica Ventriglia, Ana Garcia de Labanca, Georgina Bendek, Romina Mariano, Estrella Levy, Masiel Vera, Isabel Giere, Bianca Vasconcelos Cordoba, María Jose Mela Osorio, Miguel A. Pavlovsky, Julio Cesar Sanchez Avalos, Cecilia Foncouberta, Mariana Juni, Maximiliano Riddick, Michele Bianchini, Beatriz Moiraghi
Journal: Blood (2020)
Pre-Emptive Use of Rituximab in Epstein-Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes
Authors: Apostolia Papalexandri, Eleni Gavriilaki, Anna Vardi, Eirini Baldoumi, Christos Demosthenous, Natasa Konstantinou, Tasoula Touloumenidou, Panagiota Zerva, Fotini Kika, Angeliki Paleta, Michalis Iskas, Ioannis Batsis, Despina Mallouri, Evangelia Yannaki, Ioanna Sakellari, Achilles Anagnostopoulos
Journal: Blood (2020)
Aggressive Smoldering Curative Approach Evaluating Novel Therapies (ASCENT): A Phase 2 Trial of Induction, Consolidation and Maintenance in Subjects with High Risk Smoldering Multiple Myeloma (SMM): Initial Analysis of Safety Data
Authors: Shaji K. Kumar, Al-Ola Abdallah, Ashraf Z. Badros, Betsy Laplant, Binod Dhakal, Melissa Alsina, Rafat Abonour, Cara A. Rosenbaum, William I Bensinger, Manisha Bhutani, Andrzej Jakubowiak, Erica Kim, Brian G.M. Durie
Journal: Blood (2020)
Nonsuperiority of the Anterior Approach to Conventional Hepatectomy for Resection of Colorectal Liver Metastasis
Authors: Iswanto Sucandy, Allan Tsung
Journal: JAMA Surgery (2020)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Surgery HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Surgery journal
Immune Profiling Evaluation of Newly Diagnose Multiple Myeloma (NDMM) Transplant Eligible (TE) Patients Treated with Daratumumab, Cyclophosphamide, Thalidomide and Dexamethasone. Preliminary Results
Authors: Allan de souza Santos, Herbert Henrique de Melo Santos, Marco Aurelio Salvino, Sarah Queiroz Silva, Larissa Ferreira Lucas, Alessandro de M. Almeida, Mariane Melo Santos, Juliana Andrade Santos, Vania T. M. Hungria, Maria da Gloria B. Arruda, Alex Torres, Edvan De Queiroz Crusoe
Journal: Blood (2020)
Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial
Authors: Atte Meretoja, Nawaf Yassi, Teddy Y Wu, Leonid Churilov, Gerli Sibolt, Jiann-Shing Jeng, Timothy Kleinig, Neil J Spratt, Vincent Thijs, Tissa Wijeratne, Der-Yang Cho, Darshan Shah, Geoffrey C Cloud, Thanh Phan, Christopher Bladin, Andrew Moey, Richard I Aviv, Christen D Barras, Gagan Sharma, Chung Y Hsu, Henry Ma, Bruce C V Campbell, Peter Mitchell, Bernard Yan, Mark W Parsons, Marjaana Tiainen, Sami Curtze, Daniel Strbian, Sung-Chun Tang, Jackson Harvey, Christopher Levi, Geoffrey A Donnan, Stephen M Davis
Journal: The Lancet Neurology (2020)
Analysis of Adct-602 Pre-Clinical Activity in B-Cell Lymphoma Models and Identification of Potential Biomarkers for Its Activity
Authors: Eugenio Gaudio, Chiara Tarantelli, Luciano Cascione, Filippo Spriano, Gaetanina Golino, Lorenzo Scalise, Emanuele Zucca, Anastasios Stathis, Patrick H Van Berkel, Francesca Zammarchi, Francesco Bertoni
Journal: Blood (2020)